Metabolic alkalosis secondary prevention

Revision as of 07:07, 21 February 2021 by Marufa Marium (talk | contribs)
Jump to navigation Jump to search

Metabolic alkalosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Metabolic alkalosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Metabolic alkalosis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Metabolic alkalosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Metabolic alkalosis secondary prevention

CDC on Metabolic alkalosis secondary prevention

Metabolic alkalosis secondary prevention in the news

Blogs on Metabolic alkalosis secondary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Metabolic alkalosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Effective measures for the secondary prevention of metabolic alkalosis include resuccitation with airway, breathing, circulation, correction of electrolyte imbalance, and removal of inciting sources.

Secondary Prevention

    • Effective measures for the secondary prevention of metabolic alkalosis include:
    • Maintenance of Airway, breathing, circulation if there is an unstable patient.
    • Correction of the underlying cause for HCO3 production.
    • Removal of inciting factors that reabsorb HCO3.
    • Patient should be monitored carefully with SaO2, Vital signs monitor and EKG.
    • Consider respiratory support in hypoxemic patient.
    • Avoid hyperventilation as it will worsen alkalemia.
    • Genetic analysis in patient with positive family history.
    • Congenital adrenal hyperplasia, Cushing syndrome, Conn syndrome evaluation and early treatment.

References

Template:WH Template:WS